Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A P Moore

Showing results (61-70 of 68) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 68 results.
Age and Ageing|April 27, 2001
Clinical measures: reliable or not?J M Gregson, M J Leathley, A P Moore, et al.
Clinical Rehabilitation|August 27, 2002
Prevalence of spasticity post strokeC L Watkins, M J Leathley, J M Gregson, et al.
Clinical Rehabilitation|June 8, 2004
Predicting spasticity after stroke in those surviving to 12 monthsM J Leathley, J M Gregson, A P Moore, et al.
Neurology|July 9, 2008
Two-year placebo-controlled trial of botulinum toxin A for leg spasticity in cerebral palsyA P Moore, R A Ade-Hall, C Tudur Smith, et al.
European Journal of Neurology|November 29, 2013
A prospective study of "undiagnosed" isolated myelopathy: II. Value of magnetic resonance imaging, evoked potentials and CSF analysisL D Blumhardt, D H Miller, P A Sandercock, et al.
Journal of the Royal College of Physicians of London|January 23, 2019
The District General Hospital as a Resource for the Provision of Neurological ServicesM D Boggild, A N Bowden, D W Chadwick, et al.
Cerebrovascular Diseases (Basel, Switzerland)|April 11, 2003
A double-blind randomised placebo-controlled evaluation of three doses of botulinum toxin type A (Dysport) in the treatment of spastic equinovarus deformity after strokeS J Pittock, A P Moore, O Hardiman, et al.
British Journal of Cancer|September 12, 2013
A phase 1 trial of imatinib, bevacizumab, and metronomic cyclophosphamide in advanced colorectal cancerR K Kelley, J Hwang, M J M Magbanua, et al.
Pageof 7

Showing results (61-70 of 68) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 68 results.
Age and Ageing|April 27, 2001
Clinical measures: reliable or not?J M Gregson, M J Leathley, A P Moore, et al.
Clinical Rehabilitation|August 27, 2002
Prevalence of spasticity post strokeC L Watkins, M J Leathley, J M Gregson, et al.
Clinical Rehabilitation|June 8, 2004
Predicting spasticity after stroke in those surviving to 12 monthsM J Leathley, J M Gregson, A P Moore, et al.
Neurology|July 9, 2008
Two-year placebo-controlled trial of botulinum toxin A for leg spasticity in cerebral palsyA P Moore, R A Ade-Hall, C Tudur Smith, et al.
European Journal of Neurology|November 29, 2013
A prospective study of "undiagnosed" isolated myelopathy: II. Value of magnetic resonance imaging, evoked potentials and CSF analysisL D Blumhardt, D H Miller, P A Sandercock, et al.
Journal of the Royal College of Physicians of London|January 23, 2019
The District General Hospital as a Resource for the Provision of Neurological ServicesM D Boggild, A N Bowden, D W Chadwick, et al.
Cerebrovascular Diseases (Basel, Switzerland)|April 11, 2003
A double-blind randomised placebo-controlled evaluation of three doses of botulinum toxin type A (Dysport) in the treatment of spastic equinovarus deformity after strokeS J Pittock, A P Moore, O Hardiman, et al.
British Journal of Cancer|September 12, 2013
A phase 1 trial of imatinib, bevacizumab, and metronomic cyclophosphamide in advanced colorectal cancerR K Kelley, J Hwang, M J M Magbanua, et al.
Pageof 7